The Mark E. Josephson 31st Annual State-of-the-Art Arrhythmia Symposium | Heart Rhythm Society

The Mark E. Josephson 31st Annual State-of-the-Art Arrhythmia Symposium

The Mark E. Josephson 31st Annual State-of-the-Art Arrhythmia Symposium

The State-of-the-Art Arrhythmia Symposium is designed to provide electrophysiologists, cardiologists, internists, and associated professionals with state-of-the-art lectures on the diagnosis, evaluation, and treatment of the entire spectrum of cardiac rhythm disorders. Case presentations and expert panel discussions with active audience participation highlight the sessions. Breakout sessions geared to Associated Professionals, General Cardiology, and Advanced EP tailor information to clinical needs.

PROGRAM DIRECTOR:

  • Francis Marchlinski, MD

LEARNING OBJECTIVES:

  • Describe the appropriate evaluation of patients with frequent PVCs and NSVT as well as indications for treatment, including ablation and antiarrhythmic medications.
  • Recognize ECG clues to detect patients at risk for sudden death.
  • Describe evaluation and new treatment for patients presenting with POTS, inappropriate sinus tachycardia and neurocardiogenic syncope.
  • Apply in practice the newest information regarding evaluation and treatment of atrial arrhythmias including screening for episodes and ablation indications, techniques, and endpoints.
  • Discuss the indications for “leadless” pacing and defibrillating devices.
  • Discuss the indications, contraindications, and complications associated with left atrial (LA) appendage occlusion and closure.
  • Review the methods, techniques, associated tools, and equipment including emerging technologies to perform catheter ablation of atrial fibrillation and flutter.
  • Recognize the use and value of new techniques and technologies employed for complex EP devices and ablation cases.
  • Describe the importance of risk modification in the treatment of atrial fibrillation.
  • Apply into practice the ECG patterns/clinical characteristics, evaluation, and treatment of patients with genetically linked arrhythmia syndromes.
  • Describe common cardiac rhythm device implantation complications and malfunction.

TARGETED AUDIENCE:

  • Cardiologists
  • Clinicians
  • Electrophysiologists
  • EPsFellows/Trainees
  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Technicians
  • Scientists
  • Academic
  • Researcher
Date and Time September 7, 2024
8:00 am - 5:00 pm
Location

Philadelphia, Pennsylvania United States of America

Topics
Ablation
Atrial Arrhythmias
Atrial Fibrillation
Device Therapy
Sudden Cardiac Arrest
Ventricular Arrhythmias
Our Sponsors
Penn Medicine
Boston Scientific
Abbott
Medtronic
iRhythm
Biosense-Webster

Membership Reminder

RENEW MEMBERSHIP